E-LIB Suche - Ergebnisse für: Rouphael, N.G.

1

Coronavirus Disease 2019 Vaccine Efficacy in Participants W..:

Sherman, Amy C ; Tuan, Jessica ; Cantos, Valeria D...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

Immunogenicity and safety of varying dosages of a fifth-wav..:

Jackson, Lisa A. ; Stapleton, Jack T. ; Walter, Emmanuel B....
Vaccine. 42 (2024) 2 - p. 295-309 , 2024

Link: https://doi.org/10.1016/..

3

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarker..:

Singh, Kanal ; Rubenstein, Kevin ; Callier, Viviane...
The Journal of Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

4

SWIFT clustering analysis of intracellular cytokine stainin..:

Mosmann, Tim R. ; Rebhahn, Jonathan A. ; De Rosa, Stephen C....
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

5

Employing influenza human challenge model to characterize a..:

Tanios, R ; Traenkner, J ; Macenczak, H...
The American Journal of the Medical Sciences. 367 (2024) - p. S360-S361 , 2024

Link: https://doi.org/10.1016/..

6

The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical v..:

Goll, Johannes B. ; Bosinger, Steven E. ; Jensen, Travis L....
Frontiers in Immunology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

The Future Ain't What It Used to Be…Out With the Old…In Wit..:

Evans, Scott R ; Patel, Robin ; Hamasaki, Toshimitsu...
Clinical Infectious Diseases. 77 (2023) Supplement_4 - p. S321-S330 , 2023

Link: https://doi.org/10.1093/..

8

Phase 1 Open-Label Dose Escalation Trial for the Developmen..:

Blazevic, Azra ; Edwards, Rachel L ; Xia, Mei...
The Journal of Infectious Diseases. 229 (2023) 5 - p. 1498-1508 , 2023

Link: https://doi.org/10.1093/..

9

How to make the Lunar and Martian soils suitable for food p..:

Caporale, Antonio G. ; Palladino, Mario ; De Pascale, Stefania...
Journal of Environmental Management. 325 (2023) - p. 116455 , 2023

Link: https://doi.org/10.1016/..

10

447. Clinical Features, Risk Factors, and Outcomes of COVID..:

Taylor, Elizabeth G ; Tippett, Ashley ; Salazar, Luis W...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

11

Heterologous versus homologous boosting elicits qualitative..:

Thompson, Elizabeth A. ; Ngecu, Wabathi ; Stoddart, Laila...
JCI Insight. 8 (2023) 10 - p. , 2023

Link: https://doi.org/10.1172/..

12

Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respi..:

Branche, Angela R ; Rouphael, Nadine G ; Losada, Cecilia...
Clinical Infectious Diseases. 77 (2023) 4 - p. 560-564 , 2023

Link: https://doi.org/10.1093/..

13

Priorities and Progress in Gram-negative Bacterial Infectio..:

Satlin, Michael J ; van Duin, David ; Tamma, Pranita D...
Clinical Infectious Diseases. 77 (2023) Supplement_4 - p. S305-S313 , 2023

Link: https://doi.org/10.1093/..

14

Therapeutic trials for long COVID-19: A call to action from..:

Bonilla, Hector ; Peluso, Michael J. ; Rodgers, Kathleen...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

15

Identification of immunodominant T cell epitopes induced by..:

Eickhoff, Christopher S. ; Meza, Krystal A. ; Terry, Frances E....
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..